Infinity Pharmaceuticals reported $393K in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
TG Therapeutics TGTX:US 237K 27K
Abbvie ABBV:US $ 4021M 259M
Amgen AMGN:US $ 1561M 157M
AstraZeneca AZN:LN 2279M 790M
Bristol Myers Squibb BMY:US $ 2471M 115M
Eisai 4523:JP Y 50738M 6516M
Eli Lilly And LLY:US $ 2072.1M 21.9M
Gilead Sciences GILD:US $ 1424M 1203M
GlaxoSmithKline GSK:LN 3645M 30M
Infinity Pharmaceuticals INFI:US $ 0.39M 0.12M
Johnson & Johnson JNJ:US $ 7598M 357M
Novartis NOVN:VX SF 3755M 245M
Pfizer PFE:US $ 10010M 399M
Seattle Genetics SGEN:US $ 87.63M 0.94M
Vascular Biogenics VBLT:US 55K 40K
YTE INCY:US $ 37.21M 1.36M